Watch Co-Founder and CEO, Chris Severn as he testifies live before Congress.| Turquoise Health Blog
In which a Loop Recorder asks a patient, “Unsubscribe?”| Turquoise Health Blog
In which an ex-revenue cycle consultant builds a Medicare Pricer for his past self| Turquoise Health Blog
The final installment in the RFI Comment Saga| Turquoise Health Blog
CMS proposes new percentile allowed amounts, a CMP reduction, doubles down on patient utility, and for the first time, looks to add utilization to hospital MRFs.| Turquoise Health Blog
Read our thoughts, peruse our ideas, and get all the info on the once indefinitely delayed prescription drug file’s new RFI| Turquoise Health Blog
The RFI includes specific questions focused on price transparency and binding cost estimates for pre-defined periods| Turquoise Health Blog
Blogging on Healthcare and Price Transparency| Turquoise Health Blog
Phase 1 Price Transparency → Phase 2 Transaction Efficiency| Turquoise Health Blog
TL; DR: Guidance, RFIs, and FAQs walk into a bar| Turquoise Health Blog
And what that means for pharmaceutical manufacturers, and providers, and payers, oh my.| Turquoise Health Blog
Hold on to your hats, and also, those FTEs| Turquoise Health Blog
When CMS publishes a long document, you best believe we’ll stay up all night reading it.| Turquoise Health Blog
From your friendly neighborhood actuary| Turquoise Health Blog
It's about time drugs prices got a dust-off| Turquoise Health Blog
Let’s take a look at the new kid on the block| Turquoise Health Blog
New executive order accelerates price transparency. Price transparency company goes bananas.| Turquoise Health Blog
Life Sciences--here’s your curtain call| Turquoise Health Blog
You know how it goes, “ask and…”| Turquoise Health Blog
In this blog, we’re focused on understanding provider sensitivity to drug contracting mechanisms and how markups influence reimbursement.| Turquoise Health Blog
From trauma centers to costs at large, we’re seeing things we’ve never seen before. Literally.| Turquoise Health Blog
Let’s add “business intelligence" into the Price Transparency Cinematic Universe| Turquoise Health Blog
Prices are stabilizing. Why are expenses still rising?| Turquoise Health Blog
Let’s explore our biggest indicators of change: competition, pricing, and power| Turquoise Health Blog
Healthcare prices have begun to converge. Here’s a detailed look into our analysis.| Turquoise Health Blog
Here’s why historical hospital rates are the real MVP of price transparency data.| Turquoise Health Blog
Planned updates are coming to our MRF Tracker in August.| Turquoise Health Blog
Early returns show more organized data and more audits| Turquoise Health Blog
Price transparency data ushers in a new benchmarking frontier.| Turquoise Health Blog
Claims data, meet price transparency data.| Turquoise Health Blog
A tale of two regulations and one pending Congressional approval| Turquoise Health Blog
It’s New, Old News. Like low-rise jeans or Benifer.| Turquoise Health Blog
The acquisition also includes key Bramble Health leadership, Molly Moore, who will join the TQ team.| Turquoise Health Blog
Set up your SME to leave a legacy behind, not utter contract chaos| Turquoise Health Blog
Self-insured employers have an average savings opportunity of 27% across 500 common healthcare services.| Turquoise Health Blog
Investment led by Adams Street Partners, with participation from Yosemite, as well as existing investors Andreessen Horowitz and BoxGroup.| Turquoise Health Blog
Get in folks, we’re going shopping.| Turquoise Health Blog
Let's learn about drug net cost recovery by leveraging price transparency data and everybody’s favorite four-wheeler.| Turquoise Health Blog
The new standard Hospital MRF format will be enforced on 7/1/24.| Turquoise Health Blog
CMS announced the deferred enforcement period is coming to an end.| Turquoise Health Blog
You can play Go-Fish or you can play Data-Go-Fish. The choice is yours.| Turquoise Health Blog